Esophageal cancer: current and emerging therapy modalities.
about
Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinomaOblongifolin C inhibits metastasis by up-regulating keratin 18 and tubulinsWeekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinomaCD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.Pilot genome-wide study of tandem 3' UTRs in esophageal cancer using high-throughput sequencing.Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation.Clinical implication of elevated human cervical cancer oncogene-1 expression in esophageal squamous cell carcinoma.Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.HDAC2 regulates cell proliferation, cell cycle progression and cell apoptosis in esophageal squamous cell carcinoma EC9706 cells.Expression and association of CD44v6 with prognosis in T2-3N0M0 esophageal squamous cell carcinoma.Targeting TRPC6 channels in oesophageal carcinoma growth.Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.Tiam1 siRNA enhanced the sensitivity of sorafenib on esophageal squamous cell carcinoma in vivo.Silencing Prx1 and/or Prx5 sensitizes human esophageal cancer cells to ionizing radiation and increases apoptosis via intracellular ROS accumulation.Down-regulation of platelet-derived growth factor-D expression blockades NF-κB pathway to inhibit cell proliferation and invasion as well as induce apoptosis in esophageal squamous cell carcinoma.Swainsonine promotes apoptosis in human oesophageal squamous cell carcinoma cells in vitro and in vivo through activation of mitochondrial pathway.Radical treatment for oesophageal cancer patients unfit for surgery and chemotherapy. A 10-year experience from the Norwegian Radium Hospital.RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway.Constitution and in vivo test of micro-porous tubular scaffold for esophageal tissue engineering.Implications of Bit1 and AIF overexpressions in esophageal squamous cell carcinoma.Dual cyclin-dependent kinase 4/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells.Lin28/microRNA-let-7a promotes metastasis under circumstances of hyperactive Wnt signaling in esophageal squamous cell carcinoma.Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway.
P2860
Q28085367-EA8E75C7-E0DB-484A-8C4B-A1B800924EA0Q30650458-407FECCD-864F-44FF-B1D2-F70D36471056Q33435812-E33A4C2B-CBCA-402D-9C1A-38DB911FAF99Q33591592-E1D11BFD-B7CD-41D9-9A65-F0F5BBEFD103Q33608707-8D117AE5-F446-4874-BC8C-25FA91429DCEQ36140675-502BFB51-8EB4-49F8-A8D1-3009CCBB20CBQ36285854-C16D5DF3-9546-41F0-BC1D-E7B3D1F971C5Q36662210-0ECAD4A5-BB05-401B-BED8-9E0A508C8124Q36907427-C74AA794-58AF-49EC-B661-FD6A686DDC38Q37594003-398F4564-900E-44E4-A31F-49761E167FE2Q37620510-3503A915-E665-4220-85A9-56F2AC9B94ADQ37710561-4BCECDC5-FE05-4142-BB3E-B6768C43CA1EQ38018063-07027EB9-4404-4333-9CB7-3E93C104EABBQ38992739-FDB51E0D-1570-46B2-9EAB-AD1A13E18AF1Q39004561-D3E444FD-E516-43BF-A69F-688353C92B21Q39237027-B32C82A5-A422-49F2-A0C5-ABA86D894A61Q39244938-2F3EDB91-A830-4405-8453-B9716F8D723EQ39295486-1AD1EA57-165B-4B98-B19E-EC46504FFA96Q39369091-77EC2264-2E31-4A11-8880-E13C98441A2AQ40699422-8D74FFFC-1EA5-4821-A2A8-3D1F97901B64Q43898949-A28E663C-7089-49A4-ACE9-988E8313A50DQ48231208-B8A28CC1-9AAF-4BFE-882E-F67BAB6CB28DQ49378912-1DA640DE-0F45-4EC1-B63B-02D89BC0E7A6Q49745178-75B151B5-A002-4C58-B120-C3C2F2640052
P2860
Esophageal cancer: current and emerging therapy modalities.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Esophageal cancer: current and emerging therapy modalities.
@en
Esophageal cancer: current and emerging therapy modalities.
@nl
type
label
Esophageal cancer: current and emerging therapy modalities.
@en
Esophageal cancer: current and emerging therapy modalities.
@nl
prefLabel
Esophageal cancer: current and emerging therapy modalities.
@en
Esophageal cancer: current and emerging therapy modalities.
@nl
P2093
P2860
P1476
Esophageal cancer: current and emerging therapy modalities
@en
P2093
Bengt Wallner
Daniel Brattström
Johan Lennartsson
Martin Dreilich
Michael Bergqvist
Simon Ekman
P2860
P304
P356
10.1586/14737140.8.9.1433
P577
2008-09-01T00:00:00Z